focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

1 Oct 2018 07:00

RNS Number : 0401C
Standard Life Private Eqty Trst PLC
01 October 2018
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") increased by 6.9% to 417.3 pence for the quarter ended 30 June 2018

· Realised gains and income during the quarter ended 30 June 2018 totalled £26.9 million (4.5% of NAV). The unrealised gains on a constant exchange rate basis were £12.0 million (2.0% of NAV). In addition, there were unrealised foreign exchange gains of £6.5 million (1.1% of NAV)

· The first quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 27 April 2018

· 98.4% by value of the portfolio was valued by the respective underlying managers at 30 June 2018

· NAV total return was 9.2% for the nine months from 1 October 2017 to 30 June 2018

· Outstanding commitments were £397.2 million at 30 June 2018

· Liquid resources were £99.3 million at 30 June 2018

 

For the quarter ended 30 June 2018, the Company's NAV increased by 6.9% to 417.3 pence per share, from 390.4 pence per share at 31 March 2018. At 30 June 2018, the Company's net assets were £641.6 million (31 March 2018 - £600.2 million). NAV total return was 9.2% for the nine months from 1 October 2017 to 30 June 2018.

 

The closing value of the Company's unquoted portfolio, which, included 56 private equity fund interests, was £541.9 million at 30 June 2018 (31 March 2018 - £518.6 million and 54 private equity fund interests). The total unrealised gains on the unquoted portfolio for the quarter ended 30 June 2018 were £18.5 million, comprising £12.0 million of unrealised gains on a constant exchange rate basis and £6.5 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) rose by 3.3% and 7.9% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.9% and 5.9% respectively, relative to sterling over the quarter.

 

During the quarter ended 30 June 2018, the unquoted portfolio generated £32.5 million of distributions (six months ended 31 March 2018 - £75.5 million). The Company funded £10.4 million of drawdowns (six months ended 31 March 2018 - £51.1 million) into the unquoted portfolio. The distributions received during the quarter generated £26.9 million of net realised gains and income, which was equivalent to a return of 5.8 times the acquisition cost of the realised investments.

 

The Company paid the first quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share on 27 April 2018. The cash cost of the dividend was £4.8 million.

 

The Company made two new fund commitments of €25.0 million and $21.5 million to Investindustrial Growth and MSouth Equity Partners IV respectively. The Company had total outstanding commitments to its 56 private equity fund interests of £397.2 million at 30 June 2018 (31 March 2018 - £360.0 million to 54 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2018, the Company had liquid resources of £99.3 million (31 March 2018 - liquid resources of £81.3 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 30 June 2018

 

On 27 July 2018, the Company paid the second quarter dividend for the year ending 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8 million. In addition, the Company declared a third quarter dividend for the year ending 30 September 2018 of 3.1 pence per ordinary share, to be paid on 26 October 2018, to shareholders on the Company's share register as at 21 September 2018.

 

During the period from 1 July 2018 to 14 September 2018, the Company funded £20.5 million of drawdowns and received £20.7 million of distributions.

 

At 14 September 2018, the Company had liquid resources of £95.1 million. The Company also had total outstanding commitments of £380.0 million.

 

The Company's estimated NAV at 31 August 2018 is also being announced today. It is anticipated that the Company will release its results for the financial year ending 30 September 2018 on or around 11 December 2018.

 

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBXGDCLGDBGIL
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.